By Stewart Eisenhart, Emergo Group
The US Food and Drug Administration has published new information online explaining how medical device manufacturers may apply and qualify for limited-scope clinical investigations known as Early Feasibility Studies (EFS).
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
The post FDA clarifies Early Feasibility Study program for innovative medical devices appeared first on MassDevice.
from MassDevice http://ift.tt/2xMaPLp
Cap comentari:
Publica un comentari a l'entrada